Search

The pharma industry spent less on drug R&D last year than at any time in the last three years and there was a fall in the number of drugs getting approval, and of products in early-stage trials

The EMA says Amsterdam Molecular Therapeutics’ Glybera for treating a serious enzyme deficiency, is not ready for approval

Stephan Tanda, a director of DSM, the Dutch life sciences company, has been appointed to head the pan-European industry body

Karolinska Institutet is making major efforts to enhance its technology transfer and commercialisation system, and is currently working on a long-term strategy for innovation and research

News that criminal gangs were awarded huge EU grants looks like an open and closed case for greater scrutiny. But actually it underlines the need for less, not more red tape